VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Long Term Provisions History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Long Term Provisions | ₹2.90 Cr | ₹10 Cr | ₹8.85 Cr | ₹7.95 Cr | ₹7.38 Cr |
What is the latest Long Term Provisions ratio of VENUS REMEDIES ?
Year | Long Term Provisions |
---|---|
Mar2025 | ₹2.90 Cr |
Mar2024 | ₹10 Cr |
Mar2023 | ₹8.85 Cr |
Mar2022 | ₹7.95 Cr |
Mar2021 | ₹7.38 Cr |
How is Long Term Provisions of VENUS REMEDIES Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2025 | ₹2.90 Cr | -71.74 | |
Mar2024 | ₹10 Cr | 15.96 | |
Mar2023 | ₹8.85 Cr | 11.21 | |
Mar2022 | ₹7.95 Cr | 7.84 | |
Mar2021 | ₹7.38 Cr | - |
Compare Long Term Provisions of peers of VENUS REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VENUS REMEDIES | ₹645.4 Cr | -5.3% | -0.8% | 20.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹393,383.0 Cr | 1.8% | -3.6% | -7.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,026.0 Cr | -2.8% | -12.1% | 24% | Stock Analytics | |
CIPLA | ₹126,159.0 Cr | 2.3% | 2.4% | -4.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,450.0 Cr | 2.9% | 6.5% | 8.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,536.0 Cr | 2% | -2.4% | -13.1% | Stock Analytics |
VENUS REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VENUS REMEDIES | -5.3% |
-0.8% |
20.7% |
SENSEX | -0% |
-2.1% |
1.1% |
You may also like the below Video Courses